GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals Alzheimer's Disease
Brigham and Women’s Hospital Initiates First Clinical Trial of Nasal Vaccine for Alzheimer’s Disease
2021-11-18
Trials & Approvals Type 1 Diabetes
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
Trials & Approvals Cardiac Disease
Moderna, AstraZeneca Tout Encouraging Trial Data for mRNA-Based Therapeutic in Cardiac Health
2021-11-16
Trials & Approvals Blood Cancer
FDA Approves First Interferon Therapy for Rare Blood Cancer
2021-11-15
Trials & Approvals CAR T-cell Therapy
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products
2021-11-10
Trials & Approvals Migraine
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Trials & Approvals Obesity
Novo Nordisk’s Weight Loss Drug Shines in Phase 3 Trial
2021-11-07
Trials & Approvals Alzheimer's Disease
Cortexyme’s Shares Implode after Alzheimer’s Disease Drug Flunks Trial
2021-10-29
Trials & Approvals Cancer
AstraZeneca’s Imfinzi Beats Standard of Care in Advanced Biliary Tract Cancer
2021-10-26
Trials & Approvals Dupixent
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
Trials & Approvals CRISPR
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Trials & Approvals Gene Therapy
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Trials & Approvals Depression
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
Trials & Approvals Nasal Spray
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
1 … 23 24 25 26 27 … 50
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top